Cytomegalovirus-specific T cell immunotherapy promotes restoration of durable functional antiviral immunity following allogeneic stem cell transplantation

Clinical Infectious Diseases

Volumn 49, Issue 12, 2009, Pages 1851-1860

  Peggs, Karl S ^a   Verfuerth, Stephanie ^a   Pizzey, Arnold ^a   Chow, Shoon Ling C ^a   Thomson, Kirsty ^a   Mackinnon, Stephen ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; EX VIVO STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IMMUNOTHERAPY; IN VIVO STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; RECIPIENT; RECURRENT INFECTION; T LYMPHOCYTE; VIRUS IMMUNITY; VIRUS REPLICATION;

ADOPTIVE TRANSFER; ADULT; AGED; CELL LINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 72049131541     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/648422     Document Type: Article

References (33)

1. Peggs K.S. Cytomegalovirus following stem cell transplantation: From pharmacologic to immunologic therapy Expert Review of Anti-Infective Therapy 2004 2 4 559-573 1. Peggs KS. Cytomegalovirus following stem cell transplantation: from pharmacologic to immunologic therapy. Expert Rev Anti Infect Ther 2004; 2:559-573 (Pubitemid 39162365)
2. Goodrich JM, Mori M, Gleaves CA, et al. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med 1991;325:1601-1607
3. Goodrich J.M. Bowden R.A. Fisher L. Keller C. Schoch G. Meyers J.D. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant Annals of Internal Medicine 1993 118 3 173-178 3. Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med 1993; 118:173-178 (Pubitemid 23034801)
4. Einsele H, Ehninger G, Hebart H, et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 1995;86:2815-2820
5. Boeckh M. Leisenring W. Riddell S.R. Bowden R.A. Huang M.-L. Myerson D. Stevens-Ayers T. Flowers M.E.D. Cunningham T. Corey L. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: Importance of viral load and T-cell immunity Blood 2003 101 2 407-414 DOI 10.1182/blood-2002-03-0993 5. Boeckh M, Leisenring W, Riddell SR, et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 2003; 101: 407-414 (Pubitemid 36077556)
6. Junghanss C. Storb R. Maris M.B. Carter R.A. Sandmaier B.M. Maloney D.G. McSweeney P.A. Corey L. Boeckh M. Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation British Journal of Haematology 2003 123 4 662-670 DOI 10.1046/j.1365-2141.2003.04671.x 6. Junghanss C, Storb R, Maris MB, et al. Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation. Br J Haematol 2003; 123:662-670 (Pubitemid 37468063)
7. Nichols W.G. Corey L. Gooley T. Davis C. Boeckh M. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: Evidence for indirect effects of primary CMV infection Journal of Infectious Diseases 2002 185 3 273-282 DOI 10.1086/338624 7. Nichols WG, Corey L, Gooley T, Davis C, Boeckh M. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors; evidence for indirect effects of primary CMV infection. J Infect Dis 2002; 185:273-282 (Pubitemid 34107239)
8. Boeckh M. Nichols W.G. The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy Blood 2004 103 6 2003-2008 DOI 10.1182/blood-2003-10-3616 8. Boeckh M, Nichols WG. The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. Blood 2004; 103:2003-2008 (Pubitemid 38326213)
9. Greenberg PD, Reusser P, Goodrich JM, Riddell SR. Development of a treatment regimen for human cytomegalovirus (CMV) infection in bone marrow transplantation recipients by adoptive transfer of donorderived CMV-specific T cell clones expanded in vitro. Ann N Y Acad Sci 1991;636:184-195
10. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992;257:238-241
11. Einsele H. Roosnek E. Rufer N. Sinzger C. Riegler S. Loffler J. Grigoleit U. Moris A. Rammensee H.-G. Kanz L. Kleihauer A. Frank F. Jahn G. Hebart H. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy Blood 2002 99 11 3916-3922 DOI 10.1182/blood.V99.11.3916 11. Einsele H, Roosnek E, Rufer N, et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 2002;99:3916-3922 (Pubitemid 35332029)
12. Peggs K.S. Verfuerth S. Pizzey A. Khan N. Guiver M. Moss P.A. Mackinnon S. Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines Lancet 2003 362 9393 1375-1377 DOI 10.1016/S0140-6736(03)14634-X 12. Peggs KS, Verfuerth S, Pizzey A, et al. Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet 2003;362:1375-1377 (Pubitemid 37338339)
13. Micklethwaite K. Hansen A. Foster A. Snape E. Antonenas V. Sartor M. Shaw P. Bradstock K. Gottlieb D. Ex Vivo Expansion and Prophylactic Infusion of CMV-pp65 Peptide-Specific Cytotoxic T-Lymphocytes following Allogeneic Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation 2007 13 6 707-714 DOI 10.1016/j.bbmt.2007.02.004, PII S1083879107001723 13. Micklethwaite K, Hansen A, Foster A, et al. Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13:707-714 (Pubitemid 46767999)
14. Cobbold M. Khan N. Pourgheysari B. Tauro S. McDonald D. Osman H. Assenmacher M. Billingham L. Steward C. Crawley C. Olavarria E. Goldman J. Chakraverty R. Mahendra P. Craddock C. Moss P.A.H. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers Journal of Experimental Medicine 2005 202 3 379-386 http://www.jem.org/cgi/reprint/202/3/379 DOI 10.1084/jem.20040613 14. Cobbold M, Khan N, Pourgheysari B, et al. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J Exp Med 2005; 202:379-386 (Pubitemid 41126955)
15. Szmania S, Galloway A, Bruorton M, et al. Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers. Blood 2001; 98:505-512
16. Fujita Y, Leen AM, Sun J, et al. Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapy. J Immunother 2008;31:665-674
17. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graftversus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18:295-304.
18. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204-217
19. Peggs K. Verfuerth S. Mackinnon S. Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: A novel culture system free of live CMV virions Blood 2001 97 4 994-1000 DOI 10.1182/blood.V97.4.994 19. Peggs K, Verfuerth S, Mackinnon S. Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions. Blood 2001; 97:994-1000. (Pubitemid 32154284)
20. Peggs K, Verfuerth S, Pizzey A, Ainsworth J, Moss P, Mackinnon S. Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigenpulsed dendritic cells. Blood 2002;99:213-223
21. Cwynarski K. Ainsworth J. Cobbold M. Wagner S. Mahendra P. Apperley J. Goldman J. Craddock C. Moss P.A.H. Direct visualization of cytomegalovirus- specific T-cell reconstitution after allogeneic stem cell transplantation Blood 2001 97 5 1232-1240 DOI 10.1182/blood.V97.5.1232 21. Cwynarski K, Ainsworth J, Cobbold M, et al. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood 2001;97:1232-1240 (Pubitemid 32183744)
22. Aubert G. Hassan-Walker A.F. Madrigal J.A. Emery V.C. Morte C. Grace S. Koh M.B.C. Potter M. Prentice H.G. Dodi I.A. Travers P.J. Cytomegalovirus- specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants Journal of Infectious Diseases 2001 184 8 955-963 DOI 10.1086/323354 22. Aubert G, Hassan-Walker AF, Madrigal JA, et al. Cytomegalovirusspecific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. J Infect Dis 2001; 184:955-963 (Pubitemid 32955111)
23. Walter EA, Greenberg PD, Gilbert MJ, et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995;333: 1038-1044
24. Perruccio K. Tosti A. Burchielli E. Topini F. Ruggeri L. Carotti A. Capanni M. Urbani E. Mancusi A. Aversa F. Martelli M.F. Romani L. Velardi A. Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation Blood 2005 106 13 4397-4406 http://www. bloodjournal.org/cgi/reprint/106/13/4397 DOI 10.1182/blood-2005-05-1775 24. Perruccio K, Tosti A, Burchielli E, et al. Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood 2005; 106:4397-4406 (Pubitemid 41775954)
25. Leen A.M. Myers G.D. Sili U. Huls M.H. Weiss H. Leung K.S. Carrum G. Krance R.A. Chang C.-C. Molldrem J.J. Gee A.P. Brenner M.K. Heslop H.E. Rooney C.M. Bollard C.M. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals Nature Medicine 2006 12 10 1160-1166 DOI 10.1038/nm1475, PII NM1475 25. Leen AM, Myers GD, Sili U, et al. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med 2006; 12:1160-1166 (Pubitemid 44527351)
26. Kottaridis PD, Milligan DW, Chopra R, et al. In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood 2000;96:2419-2425
27. Chakraverty R. Peggs K. Chopra R. Milligan D.W. Kottaridis P.D. Verfuerth S. Geary J. Thuraisundaram D. Branson K. Chakrabarti S. Mahendra P. Craddock C. Parker A. Hunter A. Hale G. Waldmann H. Williams C.D. Yong K. Linch D.C. Goldstone A.H. Mackinnon S. Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen Blood 2002 99 3 1071-1078 DOI 10.1182/blood.V99.3.1071 27. Chakraverty R, Peggs K, Chopra R, et al. Limiting transplantationrelated mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. Blood 2002; 99: 1071-1078 (Pubitemid 34525573)
28. Peggs K.S. Hunter A. Chopra R. Parker A. Mahendra P. Milligan D. Craddock C. Pettengell R. Dogan A. Thomson K.J. Morris E.C. Hale G. Waldmann H. Goldstone A.H. Linch D.C. MacKinnon S. Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation Lancet 2005 365 9475 1934-1941 DOI 10.1016/S0140-6736(05)66659- 7, PII S0140673605666597 28. Peggs KS, Hunter A, Chopra R, et al. Clinical evidence of a graft-versusHodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation. Lancet 2005;365:1934-1941 (Pubitemid 40797503)
29. Gratama JW, van Esser JW, Lamers CH, et al. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 2001; 98:1358-1364
30. Gamadia LE, Remmerswaal EB, Weel JF, Bemelman F, van Lier RA ten Berge IJ. Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. Blood 2003; 101:2686-2692
31. Gratama JW, Brooimans RA, van der HB, et al. Monitoring cytomegalovirus IE-I and pp65-specific CD4(+) and CD8(+) T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations. Cytometry B Clin Cytom 2008; 74: 211-220
32. Chakrabarti S. Mackinnon S. Chopra R. Kottaridis P.D. Peggs K. O'Gorman P. Chakraverty R. Marshall T. Osman H. Mahendra P. Craddock C. Waldmann H. Hale G. Fegan C.D. Yong K. Goldstone A.H. Linch D.C. Milligan D.W. High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: Potential role of Campath-1H in delaying immune reconstitution Blood 2002 99 12 4357-4363 DOI 10.1182/blood.V99.12.4357 32. Chakrabarti S, Mackinnon S, Chopra R, et al. High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. Blood 2002;99:4357-4363 (Pubitemid 34627201)
33. Sylwester AW, Mitchell BL, Edgar JB, et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 2005; 202:673-685